Researchers developed the seats to measure biometrics during ‘natural’ processes
With 1 million new cases of congestive heart failure diagnosed each year, a revolutionary product is making it easier for hospitals to monitor patients with the condition in the comfort of their own homes.
A toilet-seat based cardiovascular monitoring system created by a team of Rochester Institute of Technology researchers, aims to lower the hospital readmission rates of patients with congestive heart failure. The toilet seats, which will be brought through the FDA clearance process by the researchers’ company Heart Health Intelligence, would be purchased by hospitals and issued to heart failure patients after discharge. The toilet seats are equipped to measure the electrical and mechanical activity of the heart, and can monitor heart rate, blood pressure, blood oxygenation levels, and the patient’s weight and stroke volume, which is the amount of blood pumped out of the heart at every beat. Algorithms analyze the data, and with further development, will alert advanced practice providers of a deteriorating condition. A report will be passed along to cardiologists who will then determine if intervention is necessary.
Nicholas Conn, a postdoctoral fellow at RIT and founder and CEO of Heart Health Intelligence, is part of the university team that developed the toilet seats.
“Typically, within 30 days of hospital discharge, 25 percent of patients with congestive heart failure are readmitted,” said Conn. “After 90 days of hospital discharge, 45 percent of patients are readmitted. And the Centers for Medicare and Medicaid Services is penalizing hospitals for readmitting patients for heart failure.”
Conn, the company’s chief executive officer, further explains that using the national average for readmission rates, the penalty alone for readmitting 150 patients is approximately $500,000 annually. The total cost of providing 150 patients with their own monitored toilet seats from HHI is $200,000. With that investment, he says, hospital systems will save more than double their initial investment within one year.
According to Conn, who earned three degrees from RIT—a bachelor’s degree and a master’s degree in electrical engineering in 2011 and 2013, respectively, and a doctoral degree in microsystems engineering in 2016—the system will pick up deteriorating conditions before the patients even realize they are symptomatic. And with the rapid data analysis, interventions can be as simple as a drug change or short office visit, instead of an admission to the hospital.
HHI, which joined RIT’s Venture Creations business incubator earlier this year, is now focused on moving the product forward. The team is heavily involved in writing grants for additional funding and networking, and human-subject testing and pre-clinical studies are well underway. Conn and his team are working on approving the product with the FDA and rolling it out across the country.
The Latest on: Congestive heart failure
via Google News
The Latest on: Congestive heart failure
- Pre-existing conditions can increase patient's risk of dying from COVID-19on October 7, 2020 at 10:48 pm
A large, international study of COVID-19 patients confirmed that cardiovascular disease, hypertension, diabetes, congestive heart failure, chronic kidney disease, stroke and cancer can increase a ...
- Rapper Scarface Asking For Kidney Donor on Social Mediaon October 7, 2020 at 9:32 pm
Rapper Scarface has turned to social media to seek help regarding his health issues. The Houston, Texas native posted a tweet on October 7, 2020 asking for a kidney donor. “I need a kidney y’all any ...
- Heart Vulnerable While Spouse Is in ICUon October 5, 2020 at 3:46 pm
Having a spouse in the ICU was linked to modestly elevated risk of a cardiovascular event, a Japanese observational study showed. Healthcare visits for cardiovascular diseases in the 4 weeks after the ...
- Health Beat: Subtle signs of heart failureon October 5, 2020 at 1:01 pm
Unlike a heart attack that hits fast and hard, heart failure can be a gradual process. Before you realize what's happening, a lot of damage can be done. Learn about ...
- BioVentrix Announces the Appointment of Cardiac Device Veteran Chris Wolff as Vice President of U.S. Saleson October 5, 2020 at 5:05 am
BioVentrix, Inc., a privately held medical device company focused on treating congestive heart failure (CHF) via Transcatheter Ventricular Restoration (TCVR), today announced that Chris Wolff has been ...
- Appeals Court Reinstates Glaxo $235.5 Million Verdict Against Tevaon October 4, 2020 at 10:06 pm
A federal appeals court on Friday reinstated a 2017 jury verdict ordering Teva Pharmaceutical Industries Ltd. to pay GlaxoSmithKline Plc $235.5 million ...
- Seattle-area startup Cardiac Dimensions raises $17.5M for heart-valve repair deviceon October 1, 2020 at 3:54 pm
Kirkland, Wash.-based Cardiac Dimensions raised a $17.5 million Series C round. The company will use the fresh cash to help sell its heart-valve repair device. Founded in ...
- Tenant with heart failure fears he'll be homeless as Manitoba ban on evictions, rent increases endson October 1, 2020 at 3:08 am
Randy Luba felt secure living in his own house in Winnipeg's West End. Now, after losing the house in a fire in 2017 and then losing his job this year due to COVID-19, Luba worries he could be ...
- Subtle signs of heart failureon September 29, 2020 at 4:53 pm
Unlike a heart attack that hits fast and hard, heart failure can be a gradual process. Before you realize what’s happening, a lot of damage can be done.
- Study finds income disparities in prevalence of heart diseaseon September 25, 2020 at 9:17 am
Being wealthy appears to reduce a person's risk for heart disease -- at least in the United States -- based on the findings of an analysis published Friday by JAMA Network Open.
via Bing News